Obesity Villains Examined

Over the years, Childhood Obesity News has pointed the finger at numerous villains who share varying degrees of culpability for obesity. Many of these have been the same entities mentioned in “Ten putative contributors to the obesity epidemic.”

Its roster of 22 authors included Dr. Joe C. Eisenmann who by now has accumulated 30 years of experience as a coach, professor, researcher, educator, applied sport scientist, and strength and conditioning coach. Children’s health, fitness, and athletic development are his missions, and “tested, trained, energized” are his watchwords.

For his own website, Dr. Eisenmann has written that,

The benefits of exercise on the child and teenage brain include:

– improved concentration, cognition, memory and academic performance
– better self-esteem
– stress reduction
– decreased likelihood of mental health issues like anxiety and depression
– decreased severity of ADHD symptoms and autism spectrum disorder

An immature, growing brain needs to assemble itself from a lot of moving parts, and research has shown that taking into account the needs of both structure and function, physical exercise plays an enormous part in helping it to do so.

Returning to the subject of obesity villains, what newsworthy candidates did the multi-author project mention? Regarding epigenetics, there is said to be basic in vitro evidence, animal evidence, and epidemiological evidence that the area is worth scrutinizing:

Animal models and human data illustrate that dysregulation of epigenetic processes can cause obesity. Recent molecular studies provide an additional link by showing that genes critical to energy balance are regulated by epigenetic mechanisms…

If the intrauterine environment of an obese woman induces developmental adaptations in her developing fetus that then predispose her offspring to obesity, feed-forward transgenerational amplification of obesity could result.

The subheading “Intrauterine and intergenerational effects” is ticked for animal evidence, ecological correlation evidence, and epidemiological evidence. Speaking of bariatric surgery patients, the report says, “Children born after maternal weight loss have a lower risk for obesity than do their siblings born before maternal weight loss.” This leads to an area called metabolic imprinting, suggesting that body weight could be regulated by epigenetic means.

Another factor discussed here before is “assortative mating,” the tendency of humans to become intimately involved with others who have similar characteristics. But they also become involved with others who have very different characteristics, and lust has always been like that. Also, it pretty much guarantees that if two obese people have a child, that child is likely to be obese.

It also implies that an overweight person is more likely to ask an overweight person on a date, having learned from experience that potential partners of normal weight don’t really consider themselves as potential partners. According to folk wisdom, it takes a lot of personality to overcome a serious weight differential. Still, as the paper indicates,

The consequences of assortative mating are complex and dependent on the “genetic architecture” of a particular trait. Given that obesity is a complex polygenic trait, models of assortative mating are quite complex.

Your responses and feedback are welcome!

Source: “Ten putative contributors to the obesity epidemic,” ncbi.nlm.nih.gov, November 2009
Source: “New Year. New Platform. New Logo,” JoeEisenmann.substack.com, 01/03/23
Source: “Exercise and Brain Health for Young People: Another Puzzle Piece to Achieving Optimal Well-Being,” Substack.com, 10/29/23
Image by Loco Steve/CC BY-SA 2.0 DEED

How GLP-1 Medications Are Changing Consumer Habits and Industry Dynamics

A paradigm shift is underway in the world of food and beverage consumption, and it’s being driven by a surprising catalyst: medications. Specifically, GLP-1 drugs, primarily used for weight loss and managing diabetes, are not only altering consumer behavior but also posing challenges to various sectors of the food industry.

Recent survey points to significant impact

A recent survey conducted by Morgan Stanley sheds light on the significant impact of GLP-1 medications on consumer spending habits, particularly in the realm of dining out and getting takeout. According to the survey, a majority of people taking GLP-1 drugs reported spending less on restaurant meals and deliveries, indicating a notable shift in their culinary preferences. In contrast, a smaller proportion indicated tightening their budgets while grocery shopping, suggesting a more nuanced effect on at-home food consumption.

Morgan Stanley analysts put it this way:

There is growing evidence that the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants… All of these dynamics suggest GLP-1 drugs’ impact across consumer sectors is set to increase as drug uptake grows and the drugs reshape behavior among a demographic group that represents a disproportionate share of calorie consumption.

Raised concerns as a consequence

The implications of this behavioral shift are reverberating across the food and beverage industry, raising concerns among stakeholders about potential revenue implications. With the market for GLP-1 drugs projected to reach a staggering $105 billion by 2030 and an estimated 31.5 million Americans expected to be on these medications by 2035, the impact on various sectors of the food industry is not to be underestimated.

However, according to CNBC, which was one of the many outlets reporting on the survey results,

[M]any food and beverage companies have reassured investors over the last few months that it’s still unclear how much those drugs will lower their revenue. Morgan Stanley also said in the survey that GLP-1s are a manageable long-term pressure on restaurants, not an “existential risk.”

Food companies survival projections

Among the most vulnerable are traditional fast-food chains and packaged food manufacturers, whose offerings often align with the high-calorie, indulgent preferences that GLP-1 medications seem to deter. Conversely, places offering healthier alternatives, such as fast-casual restaurants focusing on fresh ingredients and nutritional transparency, are better positioned to weather the storm of changing consumer habits.

In particular, brands like Cava, Chipotle, Sweetgreen, and Starbucks stand out as adaptable to the evolving consumer landscape, while legacy fast-food chains like Jack in the Box, Wendy’s, and Shake Shack may face greater pressure to innovate and cater to health-conscious clientele.

Similarly, packaged food companies like Hershey are identified as particularly vulnerable due to their reliance on traditional, calorie-dense snacks. On the flip side, companies offering healthier alternatives, such as Vital Farms and Simply Good Foods, are poised to benefit from the growing demand for nutritious options.

What foods might be out?

The survey also highlights the impact of GLP-1 medications on specific food categories, with consumers reporting reduced consumption of snacks, confections, and sugary drinks. This trend is expected to translate into a decline in the consumption of certain products, including ice cream, cakes, candies, and regular sodas, by 2035.

GLP-1 drugs are going for your vices, too

Wait, there’s more. It’s not just the food but tobacco and alcohol, too. The report suggests that users of GLP-1 drugs, including Ozempic, are reducing their consumption of tobacco and alcohol while on these medications due to appetite suppression effects. Survey data shows significant reductions in both tobacco and alcohol consumption after starting the treatment.

While caution is advised in drawing conclusions, anecdotal evidence suggests these drugs might help curb addictive behaviors. Clinical trials are underway to explore this further. Morgan Stanley predicts continued growth in the GLP-1 market, projecting a $105 billion global market by 2030, with around 31.5 million users in the U.S. by 2035.

The bottom line

The rise of GLP-1 medications is reshaping consumer habits and posing challenges to various sectors of the food and beverage industry. While some companies may face headwinds, others have the opportunity to innovate and cater to the growing demand for healthier options. As the landscape continues to evolve, adaptation and responsiveness to changing consumer preferences will be key for businesses seeking to thrive in this new era of food consumption.

Your responses and feedback are welcome!

Source: “Most people on weight loss drugs are spending less on restaurants and takeout, survey says,” CNBC, 4/20/24
Source: “Ozempic is coming for the alcohol and tobacco industries next,” Quartz, 4/23/24
Image by Jonathan Borba on Unsplash

A Putative Contributor, Continued

We were just saying how researchers have determined that the little bugs inside us have global implications, including the obesity epidemic. Human adenoviruses can evade our body’s immune response, and just hang on forever, sapping our physical resources and convincing us that life is not worth living.

Scientifically they are known as HAdV, and the tiny pests come in more than a hundred varieties or serotypes, of which at least 67 cause disease in humans. They have been sorted into groups A through F, of which groups A, C, and D contain serotypes linked to obesity.

A particularly ornery specimen, known as E4orf1-D36, has a dire potential in humans. It “activates adipogenesis and metabolic glucose and lipid regulation, potentially contributing to obesity-related disorders.” Very recent research has led to suspicion that the bug might be able to regulate the immune responses of its host, and if so, that would be a very big deal:

Modulating E4orf1-mediated adipogenesis, metabolic pathway activation or pro-survival functions in model systems could be a powerful tool for identifying potential therapeutic targets for obesity-associated diseases.

In laboratory glassware, a similar substance is now viewed suspiciously:

Meta-analyses support the association or risk between HAdV-D36 infection and the development of obesity but seems to be more linked to the accumulation of subcutaneous fat rather than visceral fat.

Another member of the gang, known as MCP-1, “plays a role in adipogenesis and recruiting monocytes and macrophages into adipose tissue, potentially contributing to insulin resistance and obesity development.”

The usual suspects

There is a very great temptation to blame the designers of roads, public spaces, and neighborhoods for the ever-growing obesity of humans all over the globe. But some skeptics scoff at that theory, and it is no wonder. Presently, the fattest people in the world inhabit geography where modern infrastructure has infiltrated the least — Samoa, Cook Islands, Niue, and the like.

However, it is possible in this case to suspect the other half of the “big two.” This would be the distribution process, such as importing to remote locales only the worst kinds of food.

The impulse to blame the built environment is understandable, and so is suspicion toward the wiles of advertisers and the complicity of manufacturers who dump all kinds of exotic chemicals into food. After all, we do need targets on which to cast the blame. Because if it’s the fault of the people themselves — if they are messing up, living incorrectly, and willfully persisting in being overweight — then we return to Square One.

It is so easy to slide back into the judgmental, punitive version of theorizing about obesity’s origins. The compulsion is strong, to specifically and definitively blame every obese person, and condemn them all as lazy, irresponsible individuals who care nothing for themselves or others.

Bring on the blame

When other factors can be credibly discounted, then it all comes back to an individual eating too much, too often. And if it is all the individual’s fault, then each overweight person is responsible for holding back human progress, as well as for costing society tons of money.

It is all too easy to conclude that every bit of ridicule and fat-shaming is well-deserved. Maybe “those people” ought to be refused airplane seats. Maybe they really don’t deserve to fly. In fact, they ought to be fat-shamed more often, because then they might quit their antisocial ways, slim down, and give the rest of us a break.

And that is just the start. Unfortunately, blame goes on from there and leads to all kinds of unacceptable thinking which, even if it were technically correct in every aspect, any attempt to turn it into public policy would be unthinkable. Aside from being morally reprehensible, it would be ineffective, which we already know from previous implementations.

Going back to “Ten putative contributors to the obesity epidemic,” we recall how its authors are suspicious of simplistic explanations like blaming the “built environment” or the way food is sold. They say,

Our point is merely that we do not have conclusive evidence that the big two or their individual elements are the preeminent contributors to the obesity. Despite the lack of solid evidence that clearly demonstrates the “culprits” are chiefly responsible for the obesity epidemic, researchers are quick to blame them even in the public eye… Such confidence in one “culprit” is then often contradicted by public health proponent advancing their favored target for intervention.

Your responses and feedback are welcome!

Source: “Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy,” NIH.gov, August 2019
Source: “E4orf1: The triple agent of adenovirus…,” ScienceDirect.com, June 2024
Source: “Ten putative contributors to the obesity epidemic,” ncbi.nlm.nih.gov, November 2009
Image by Dr. Yale Rosen Atlas of Pulmonary Pathology/CC BY-SA 2.0 DEED

A Putative Contributor

To catch up, please glance back at “Obesity Villains Reconsidered” and/or “Obesity Villains Exonerated.” These posts are based on a paper that cast doubt on or debunked some commonly held beliefs about the causes of obesity and supported others.

Either way, it encompassed some interesting material and provided a starting place to reassess various bits of received wisdom, because…

[…] scientists widely and readily acknowledge that multiple factors contribute to obesity including but not necessarily limited to genetic, dietary, economic, psychosocial, reproductive, and pharmacologic factors.

Among other ideas, the authors reconsidered the notion of the heavily criticized institution known as the “built environment.” In one case, they found a study that examined two racially same but economically different neighborhoods, and concluded that “levels of leisure walking and physical activity were not higher, and rates of obesity were not lower in the non-poor neighborhood with better maintenance, more sidewalks and recreational facilities.”

In another upset, the authors discovered that although high fructose corn syrup has been enthusiastically demonized, an American Medical Association position paper said “it appears unlikely that HFCS contributes more to obesity or other conditions than sucrose.” Similarly, although anti-obesity warriors hate vending machines, and devote a lot of energy to lobbying against their presence in schools, the actual evidence against the machines as obesity villains is underwhelming:

Our point is merely that we do not have conclusive evidence that the big two or their individual elements are the preeminent contributors to obesity. Despite the lack of solid evidence that clearly demonstrates the “culprits” are chiefly responsible for the obesity epidemic, researchers are quick to blame them even in the public eye…

Such confidence in one “culprit” is then often contradicted by public health proponent[s] advancing their favored target for intervention.

Due to the “complex reality” of the situation, the authors point out that some factors are not actionable in any practical way. For instance, a lot of adults have gotten fat because they quit smoking. But no responsible member of any profession would suggest that anyone should resume the nicotine habit for the sake of weight control.

Regarding the role of bacterial products in regulating metabolism and body weight, a category that has been explored is infection, because…

[…] the possible contribution of infections in the etiology of human obesity is often overlooked. Canine distemper virus (CDV) was the first reported obesity promoting virus… In mice infected with CDV, obesity develops after acute infection has abated and when no virus is detectable.

Also, there is a suspicion that the role played by bacterial products in metabolism and body weight regulation has not been considered. In this area of investigation, a lot of crazy things have been observed. For instance, take visceral fat in chickens. “Paradoxically, the increased adiposity due to SMAM-1 [an avian adenovirus] infection was accompanied by a reduction in serum cholesterol and triglycerides.”

Ad-36 is a human adenovirus capable of increasing adiposity not only in chickens but in non-human primates. In one experiment, it is said to have “increased whole-body insulin sensitivity and enhanced expression of genes involved in the adipogenic and de-novo lipogenesis pathway…” — and it spreads very fast.

Only a few adenovirus subgroups have been examined relative to adiposity. “Adipogenic potential of remaining the 45 known human adenoviruses has not been tested.” Of course, that was in 2009, so additional research has surely changed the statistic. Still, a search for several keywords reveals that since then, not much seems to have been done toward finding out about the adipogenic potential of the remaining almost four dozen varieties.

A federal government page says,

Sometimes the virus can be shed (released from the body) for a long time after a person recovers from an adenovirus infection, especially among people who have weakened immune systems. This “virus shedding” usually occurs without any symptoms, even though the person can still spread adenovirus to other people.

Just a few more words about human adenoviruses, or HAdVs, which are associated with “an array of diseases”:

HAdV is classified into seven groups (A-F). There are more than 100 serotypes, and approximately 67 serotypes (1-67) are known to be pathogenic in humans… HAdV can evade the immune response and produce persistent or latent infections.

Your responses and feedback are welcome!

Source: “Ten putative contributors to the obesity epidemic,” ncbi.nlm.nih.gov, November 2009
Source: “Transmission, CDC.gov, undated
Source: “Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy,” NIH.gov, August 2019
Image by Dr. Yale Rosen Atlas of Pulmonary Pathology/CC BY-SA 2.0 DEED

GLP-1 Agonist Drugs Show Promise for Treating More Conditions

GLP-1 agonist drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, initially used for weight loss and diabetes, are showing promise for treating various conditions beyond their original scope. Novo Nordisk’s Ozempic and Wegovy, along with Eli Lilly’s Mounjaro and Zepbound, are leading this trend.

Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound — brand names for drugs semaglutide and tirzepatide — are far and away the most famous members of a booming class of medications known as GLP-1 agonists. These medications mimic a gut hormone called GLP-1. They were initially approved to treat diabetes and, more recently, obesity, and with more and more people using the drugs, signs of other potential benefits are starting to emerge.

For one, Novo Nordisk gathered enough data to prove this and scored approval from the Food and Drug Administration last March to add cardiovascular benefits to Wegovy’s label (experts expect Zepbound will be shown to have similar heart benefits). And earlier this month Eli Lilly issued a press release notifying the world that it was eying a label expansion for Zepbound after a late-stage trial found that the drug “meaningfully improved sleep apnea symptoms,” which means the drug “has the potential to be the first pharmaceutical treatment for the underlying disease,” according to Lilly’s senior vice president for product development Jeff Emmick.

To expand on this, Eli Lilly’s weight loss drug Zepbound has shown effectiveness in reducing obstructive sleep apnea in adults with obesity, potentially becoming the first pharmaceutical treatment for this condition. The drug led to significant reductions in sleep apnea events in two studies, with participants experiencing an average weight loss of around 20%.

These findings, though not yet peer-reviewed, indicate the drug’s potential to address a major health issue beyond weight loss. Experts believe these results could influence insurance coverage for the drug, and Lilly plans to present additional details at the American Diabetes Association conference in June and submit them to the FDA later this year.

Additionally, companies like Novo Nordisk, Eli Lilly, Boehringer, and Zealand Pharma are exploring GLP-1 drugs as a potential treatment for fatty liver disease. As a recent Forbes article points out:

Studies also indicate the GLP-1 class could potentially help with a range of brain disorders, where they potentially help boost mood, cognitive function and alleviate symptoms for conditions including Parkinson’s, Alzheimer’s, depression, bipolar disorder and anxiety, areas that have long been notorious sticking points for pharmaceutical development.

Substance use disorders and addiction is another promising avenue following reports of diminished cravings among people taking GLP-1 drugs, though scientists are still working to figure out why — the drug could feasibly act on parts of the brain and nervous system as these also produce the GLP-1 hormone or have relevant hormone receptors for it — and confirm whether the medications can indeed curb addiction.

Of course, post-approval reports are crucial, as they may reveal unforeseen negative effects. Still, the weight loss market has no indication of slowing down. On the contrary, analysts estimate that the weight loss drug market could be worth at least as much as $100 billion by 2030, with Novo Nordisk and Eli Lilly currently dominating it. These companies’ extensive data and label expansions set a high bar for competitors.

Your responses and feedback are welcome!

Source: “Drugs Like Ozempic And Mounjaro Could Treat Other Conditions — Here’s What Scientists Are Looking At,” Forbes, 04/18/24
Source: “Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company says,” NBC News, 04/17/24
Image by Isabella Fischer on Unsplash

Obesity Villains Exonerated

This is an extension of the recent post, “Obesity Villains Reconsidered,” which discusses an interesting 2009 paper in which multiple authors looked closely at many accepted or alleged causes of obesity. One of their reactions was to divide pretty much all those possible causes into two subheadings: “food marketing practices” and “institutionally-driven reductions in physical activity” — which for convenience, they called the “big two.” But they also went on to propose quite a number of other causes, in a “more thorough discussion of factors that may be contributing to the obesity epidemic.”

Myopic emphasis

They proposed that there has been a narrowly focused concentration on two very big concepts, both having to do with energy: how to get it, and how to spend it. At the same time, the characterization of those categories has grown ever more broad. Human nature is such that, in many departments of life, we seem unable to count higher than two. A thing is either this or that. It is either intake or output — but that insistence on duality is a sticking point.

The paper titled “Ten putative contributors to the obesity epidemic” spells out that while each unit of the “big two” contains many problematic elements, there are also quite a number of other potential hazards to worry about. They fall outside the purview of either intake or expenditure, yet still need to be accounted for. This paragraph encapsulates the crux of the problem:

[E]ven though some elements of the big two do very likely play some role in influencing obesity levels, we believe that an unquestioned assumption of their preeminence has led to the possibly ill-advised expenditure of public effort and funds on programs aimed at reducing population levels of obesity and has also reduced the exploration of other potential causes and the alternative obesity reduction programs that might stem from their identification.

Consequently, these authors point the finger at some hitherto blameless suspects. More intriguingly, after examining the cases against a few traditionally acknowledged obesity villains, those factors are let off the hook. Take fast-food establishments. A 2008 study showed that although people might consume a boatload of calories at a restaurant, “they largely compensated by eating less at other occasions…”

Of course, that all transpired some years back. Since then, the evidence against fast food has mounted and multiplied. There are indications that people who eat home cooking absorb less sugar and fat, and have lower cholesterol levels. Also, at home, there is more opportunity for portion control, although that could backfire. (“It’s my kitchen, I paid for the food, and by golly, I’ll eat as much of it as I please.”) Another element of domestic culinary art is that, of course, the (traditionally female) cook has more control over what ingredients go into a meal in the first place.

PE still counts

A 2012 meta-study looked at data from “observational studies, 20 cross-sectional studies, and 8 prospective cohort studies.” However, there were methodological differences between those studies, and the conclusions drawn turned out to be “far from conclusive.” A 2018 paper said it all in the title: “Frequency of Eating Out at Both Fast-Food and Sit-Down Restaurants Was Associated With High Body Mass Index in Non-Large Metropolitan Communities in Midwest.” No doubt, plenty of evidence for either claim could be found by a motivated seeker.

As for Physical Education in schools, the evidence that it has decreased is not convincing, and furthermore, “much evidence suggests that standard PE classes have no appreciable impact on obesity levels.” Again, this was stated in 2008, so it is appropriate to look for something fresher — like two reports from 2023. The first, from the University of Texas at Austin, bluntly states in its title, “Physical Education Policies in Schools Have Not Curbed Childhood Obesity.”

Over the past few years, many states have supposedly adopted the 150-minutes-per-week standard. But…

Researchers found that schools largely disregarded state laws and did not increase the time that elementary students actually spent in PE or recess. Relative to states that did not change their laws, states that passed increases did not see a decline in children’s body mass index, overweight prevalence or obesity prevalence.

“Closer oversight of schools would be needed to improve compliance with state PE laws,” said Paul von Hippel […] who co-authored the study. “Yet, even with better compliance, we estimate PE classes just don’t burn enough calories to make a noticeable impact on obesity. At least not as they’re currently conducted.”

But to balance the scales, another fairly contemporary article is titled, “PE classes vital to children’s physical and mental health.” It quotes pediatrician Dr. Rebecca N. Dudovitz affirming that PE classes are definitely helpful, especially post-pandemic, for both the physical and mental health of children. And as always, there are obstacles to the achievement of necessary goals. In far too many cases…

PE class is the only time exclusively set aside for exercise. That’s particularly true for children who do not have access to safe places to play outside of school. Families of students in underserved communities may not have the same resources or privileges of a safe environment for exercise in their neighborhood.

Do parents need to play a role in ensuring that kids move enough? Absolutely. Dr. Dudovitz makes five recommendations:

  1. Carve out daily time for physical activity
  2. Use fun competition as a motivator
  3. Incorporate nutrition (a healthy diet reinforces performance and ambition to stay fit)
  4. Encourage your child to join a sports program or organized after-school fitness activity
  5. Limit time on video games and cell phones

Your responses and feedback are welcome!

Source: “Ten putative contributors to the obesity epidemic,” ncbi.nlm.nih.gov, November 2009
Source: “Association between eating out of home and body weight,” ncbi.nlm.nih.gov, February 2012
Source: “Frequency of Eating Out at Both Fast-Food and Sit-Down Restaurants Was Associated With High Body Mass Index in Non-Large Metropolitan Communities in Midwest,” ncbi.nlm.nih.gov, Jan 2018
Source: “Physical Education Policies in Schools Have Not Curbed Childhood Obesity,” UTexas.edu, 03/21/23
Source: “PE classes vital to children’s physical and mental health,” UCLAHealth.org/ 04/08/22
Image by Jaguar MENA/CC BY 2.0 DEED

Obesity Villains Reconsidered

The word “multifactorial” has been mentioned here many times before. Thanks to life being how it is, a plethora of factors will always be at work, on us and around us, in pretty much every aspect of human existence.

Take the example of auto accidents. Distracted driving is the main cause of them, and then there’s speeding, and drunk driving. Relative to those biggies, the collective impact of deer collisions may be small — but they are still potentially fatal; along with fog, potholes, tailgating, reckless lane-hopping, and other factors that despite being not so statistically prominent, are nonetheless meaningful. Even if deer cause only a fraction of a percent of vehicle accidents, they are still a factor. If those eventualities could be eliminated as factors, so much the better.

The same is true of some of the less frequent or more unlikely-sounding reasons for what has been called the obesity epidemic. Obesity appears to follow the pattern of having not only a gigantic, pervasive cause or two but an arsenal of little tricks to bring people under its sway.

Throwing ideas out there

Inspired by the news that over a billion humans are now obese, Joe Eisenmann, Ph.D., reflects on the many contributing factors that gang up to cause the ongoing epidemic. This writer is described as (among other things) a diverse scholar-practitioner and youth sports coach, who has been on the faculty of four different universities and published 180 scientific papers.

As an academic researcher, some years ago he was included in the group of highly respected obesity scholars who, with Dr. David Allison, wrote a paper called “Ten Putative Contributors to the Obesity Epidemic.” Bearing in mind that “putative” means commonly supposed, accepted or assumed, they are…

microorganisms
epigenetics
increasing maternal age
greater fecundity among people with higher adiposity
assortative mating
sleep debt
endocrine disruptors
pharmaceutical iatrogenesis
reduction in variability of ambient temperatures
intrauterine and intergenerational effects

That entire list would certainly not be endorsed by Dr. Pretlow, but illustrates what the authors meant by saying, “Human weight, body composition and obesity, like other human traits, are part of the multi-faceted complicated human phenotype.” The general multifaceted idea is sound, although experts have different opinions about specifics. The Abstract section of the work says,

While the evidence is strong for some contributors such as pharmaceutical-induced weight gain, it is still emerging for other reviewed factors. Considering the role of such putative etiological factors of obesity may lead to comprehensive, cause specific, and effective strategies for prevention and treatment of this global epidemic.

The authors seem to suggest that, when such important answers are sought, it is important to look at everything, in order to know what should be discarded. This paper proposes that the commonly understood reasons for obesity can be generally sorted into two groups — food marketing practices and institutionally-driven reductions in physical activity — which for convenience, are called the “big two.”

The authors say,

Our purpose here is to expand upon our brief discussions elsewhere and offer a more thorough discussion of factors that may be contributing to the obesity epidemic beyond those conventionally included within the big two.

Each major category includes a large number of sub-categories, some of which are manifestly more harmful than others — but they all do their share, in the big picture. On one hand, a marketing practice that can be regulated and enforced is the inclusion of accurate labels that make full disclosure of ingredients, caloric value, sell-by date, genetic interference, allergens, etc.

But much more difficult matters come under that marketing practice heading, too — like “food deserts.” Government bureaucracies cannot force corporations to build grocery stores where they don’t want to, and that’s that. “Institutionally-driven reductions in physical activity” are not easily addressed, either. It will take more than a few bike lanes and standing desks to make an appreciable dent in obesity.

Your responses and feedback are welcome!

Source: “The 25 Top Causes of Car Accidents in the US,” SeriousAccidents.com, undated
Source: “The Obesity Epidemic — more complicated than diet and exercise,” Substack.com, 03/04/24
Source: “Joe Eisenmann, PhD,” VoltAthletics.com, undated
Source: “Ten putative contributors to the obesity epidemic,” ncbi.nlm.nih.gov, November 2009
Image by Juhan Sonin/CC BY 2.0 DEED

Understanding the “Ozempic Baby” Phenomenon

In the realm of weight loss medications, few have captured attention quite like Ozempic. Promising not just significant weight loss but also sustainable results, Ozempic and other GLP-1 drugs have garnered a reputation for effectiveness. However, beyond their intended purpose, a curious trend has emerged — the rise of what some term “Ozempic babies.”

This phenomenon, where women report getting pregnant while on Ozempic, has sparked intrigue and concern alike. The internet is rife with women sharing their stories, and every platform — from Reddit to TikTok to mainstream news channels and heavyweights like The Washington Post — is buzzing.

So, while the drug hasn’t been approved for fertility enhancement, the correlation between weight loss and fertility, coupled with Ozempic’s impact on birth control, sheds light on this unexpected occurrence. Let’s take a look at the two main reasons this is happening and why fertility experts advise against getting pregnant while taking Ozempic.

Weight loss can lead to increased fertility

Last week, The Bump published an article by Associate Editor Wyndi Kappes that pointed out two possible reasons that taking Ozempic can lead to an unexpected pregnancy. Kappes interviewed Karen Wheeler, M.D., FACOG, a reproductive endocrinologist at Reproductive Medicine Associates, who highlighted the link between weight loss and enhanced fertility. Dr. Wheeler said:

We know that weight loss can increase the rate of ovulation in women with irregular periods… Women who lose weight with Ozempic who were not previously ovulating may start to ovulate and if not using effective contraception, may get pregnant while on Ozempic.

Also, lower BMI resulting from weight loss can improve pregnancy rates, especially in assisted reproductive technology, according to Dr. Wheeler.

Ozempic’s impact on birth control

The second reason that women may be getting pregnant on Ozempic has to do with the drug’s effect on birth control. Dr. Wheeler pointed out that while no direct studies correlate Ozempic with decreased birth control effectiveness, the drug’s influence on gastric processes could affect pill absorption. This is especially true if Ozempic is causing such side effects as nausea and vomiting.

Lauren Bishop, M.D., ob-gyn, an assistant professor of obstetrics and gynecology at Columbia University Fertility Center, also pointed out that weight loss medications, in general, may decrease the efficacy of oral contraceptive pills. She said:

These medications can slow how the stomach is processing its contents, thus altering how birth control pills are absorbed and processed.

Why getting pregnant on Ozempic isn’t recommended

Despite the potential fertility benefits, caution is warranted. Drs. Wheeler and Bishop emphasize the lack of studies on Ozempic’s safety during pregnancy. Animal studies hint at adverse fetal outcomes, indicating a potential risk for human pregnancies. Dr. Wheeler explained:

Pregnant rats who were given Ozempic had increased rates of fetal death, structural abnormalities and growth alterations… It can take up to 6 weeks for Ozempic or similar medications to be gone from the body, so someone who is planning to conceive should stop Ozempic at least 2 months prior to conception.

In light of these findings, women on Ozempic are advised to take extra precautions regarding birth control. Barrier methods or long-acting reversible contraception are recommended until more is understood about the drug’s interaction with contraceptives and its effects on pregnancy.

Dr. Wheeler also underscored the importance of seeking professional guidance when navigating fertility and weight loss. “If you are overweight or obese and trying to conceive, please speak with your ob-gyn or fertility specialist about the pros and cons of different weight loss therapies,” she said.

The bottom line

While Ozempic (and similar GLP-1 drugs) may offer weight loss benefits, its role in conception remains uncertain and potentially risky. Until more studies emerge, taking Ozempic and pregnancy shouldn’t coincide. Women are encouraged to explore alternative weight-loss therapies and consult with healthcare providers to make informed decisions.

Your responses and feedback are welcome!

Source: “Ozempic Babies: Experts Weigh in on the Drug’s Effect on Fertility,” The Bump, 4/10/24
Image by Hollie Santos on Unsplash

What, No Party? No Cake?

A billion of anything is quite a landmark. A person might think it would warrant some kind of celebration. But no. The Lancet just went with a sober headline: “More than one billion people in the world are now living with obesity, global analysis suggests.” Here’s more:

In total, an estimated nearly 880 million adults were living with obesity in 2022 (504 million women and 374 million men)… Combined with the 159 million children living with obesity in 2022, this is a total of over one billion people affected by obesity in 2022.

The article talks about a study funded by a trio of venerable institutions and conducted by the NCD (Non-Communicable Disease) Risk Factor Collaboration, described as “a worldwide network of over 1,500 researchers and practitioners.” Ever since 1990, when global health authorities apparently started seriously keeping track, children and adolescents have become more and more obese. At the same time…

[…] rates of underweight fell among children, adolescents and adults, leading to obesity becoming the most common form of malnutrition in many countries.

Doesn’t that sound crazy? Even more confounding is a quotation from one of the study’s senior authors, Professor Majid Ezzati of Imperial College London, identifying the answer to both problems as the same: namely, to “significantly improve the availability and affordability of healthy, nutritious foods.” He also makes a point of mentioning the huge demographic shift. In the 1990s, obesity was a condition that mainly affected adults. Now, children and adolescents are experiencing obesity on a scale that would have been impossible to imagine back then.

From the report, here are just a few examples of the statistics:

USA obesity rate among girls in 1990 —   11.6% In 2022 — 19.4%
USA obesity rate among boys in 1990 —   11.5% In 2022 — 21.7%
UK obesity rate among girls in 1990 —     4.7% In 2022 — 10.1%
UK obesity rate among boys in 1990 —     4.3% In 2022 — 12.4%
China obesity rate among girls in 1990 —      0.6% In 2022 —   7.7%
China obesity rate among boys in 1990 —      1.3% In 2022 — 15.2%

Despite the most rigorous controls and conscientious procedures, it is doubtful that any study can ever guarantee total accuracy. Here is an example of why. Although more than 1,500 researchers took part in this effort, all the measurements on which it was based were of BMI (body mass index). While by no means totally discredited, BMI has been recognized as an imperfect standard, and many experts would much rather see everyone in the field switch over to the waist-to-height ratio.

Even with enthusiastic endorsement and total cooperation from the majority of professionals in the field, it is unlikely that such a drastic change could take hold completely within a short time span. But even more discouraging is the plain fact that, if BMI is a misleading criterion, when 1,500 researchers report conclusions based on it, that essentially translates into “misleading multiplied by 1,500.”

The authors of course acknowledge the inevitable shortcomings faced by any endeavor of this massive scale:

While BMI is an imperfect measure of the extent and distribution of body fat, it is widely recorded in population-based surveys, making analyses such as these possible. Some countries had little data and three had no studies, meaning their estimates are more uncertain. There were also differences in data availability by age group, with fewer data available for those aged five to nine years, and people aged over 65 years, increasing the uncertainty of estimates for these age groups.

“This new study highlights the importance of preventing and managing obesity from early life to adulthood, through diet, physical activity, and adequate care, as needed,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

If human nature as it relates to food and eating were the only drawback, the prognosis would not be good. But several other factors are involved, mostly based on human nature as it impinges on everything else concerned with life on earth. These pessimistic words are from study co-author Dr. Guha Pradeepa of the Madras Diabetes Research Foundation:

The impact of issues such as climate change, disruptions caused by the COVID-19 pandemic, and the war in Ukraine risk worsening both rates of obesity and underweight, by increasing poverty and the cost of nutrient-rich foods. The knock-on effects of this are insufficient food in some countries and households and shifts to less healthy foods in others.

Your responses and feedback are welcome!

Source: “The Lancet: More than one billion people in the world are now living with obesity, global analysis suggests,” EurekAlert.org, 02/29/24
Image by Simeon W/CC BY 2.0 DEED

Descriptions and Terminology

Here is an example of everyday craziness that we somehow manage to calmly assimilate and probably not even notice. A person may speak of raising funds for charity. Of course we know what that means. They want to collect some money from people who have it, to spend on helping people who don’t. But… a person may speak of raising funds for birth defects, or for COVID-19. Of course we know what that means. They hope to finance some needed research that can put a stop to deformed fetuses or coronavirus.

But despite using the same operative word, “for,” the two ambitions are exactly opposite. In the first instance, “for” charity means that the speaker is in favor of helping the less fortunate, and recognizes the granting of aid as a good that should be supported. In the second case, collecting money “for” COVID-19 means that the speaker is against the virus, and recognizes it as an evil that should be eradicated.

People have gone out and demonstrated, and have marched for peace, for babies, for life, and for justice. People have also identified themselves, proudly, as marching for cancer. Obviously, this is a complete contradiction in terms, a verbal construction that is incorrect, meaningless, and ridiculous. And yet it is recognized as legitimate by those who march, and those who contribute to the cause. Conscientious and caring people have “marched for meals,” and responsive and responsible people have “marched for hunger.” And yet, logic tells us that those are opposite goals, of which one is being misidentified.

April Fool all year long

The meme at the top of this page is a joke. The fact that “stressed” and “desserts” spell each other backwards is totally insignificant, and no sane person would believe otherwise. One trait of mental illness is that an individual tends to get all wrapped up and bogged down in seemingly meaningful coincidences in numbers and words. A feverish, wide-eyed obsessive may reveal in a hushed tone that God is dog spelled backwards, earnestly convinced that this means something. The listener may argue that in French, the two words are Dieu and chien, which do not spell each other backwards — but to no avail.

Are other languages as confusing as English? How do we know when some linguistic detail has meaning, versus when it is just random chance?

Lots of words

We have all kinds of terminology for unhealthy consumption patterns — stress eating, nervous eating, recreational eating, binge eating, compulsive eating, emotional eating, and so on.

And then, there is comfort eating. Aren’t they, at the bottom, all the same entity? The first group of terms represents eating caused by stress, nerves, boredom, unruly emotions, irresistible compulsion, etc. Those are names for what causes unwholesome consumption. The single term, comfort, is a name for the result of unhealthy eating in the person’s body and mind — at least, temporarily — which is an escape from stressful discomfort. Whether looked at from one end or the other, it’s all the same pathological behavior.

It sure looks like stress eating is the same as comfort eating. A person is trying to escape stress and to achieve comfort, isn’t that what it all boils down to? The stress eater, the nervous eater, the bored eater, and the emotionally traumatized eater, all have the same goal: to transform themselves into someone who is no longer troubled by stress, nerves, hurt feelings, or whatever; and to experience comfort instead. One moment — when seeking relief — you’re a stress eater. The next moment — having obtained relief — you’re a comfort eater. Or more likely, you were both, all along.

A while back, E. Leigh Gibson published a paper that said,

In the academic literature, the normal understanding of comfort eating is eating to relieve negative emotions or affect (typically depression, anxiety or anger), which is synonymous with “emotional eating” (at least where the definition is restricted to negative emotions), the latter being the more commonly used term in such literature… Another term with similar meaning is ‘stress eating’, that is eating induced by stress…

Gibson also says,

Human and animal theories and models of emotional or stress-induced eating show some convergence, and may incorporate genetic predispositions such as impulsivity and reward sensitivity, associated with dopamine dysregulation underlying incentive salience.

Recently, however, as Dr. Pretlow points out, both genetics and dopamine dysregulation have been doubted.

In creating a definition, another little wrinkle shows up. Okay, comfort eating is the sort induced by negative affect, like depression, anger, indecision, rumination (too much thinking), workplace stress, emotional turmoil — anything negative. Which technically could include plain old gnawing physiological hunger. So, under that definition, just regular everyday eating to satisfy the demands of the body is also comfort eating!

Your responses and feedback are welcome!

Source: “The psychobiology of comfort eating: implications for neuropharmacological interventions,” NIH.gov, Sept 2012
Image by Pat Hartman

FAQs and Media Requests: Click here…

Profiles: Kids Struggling with Weight

Profiles: Kids Struggling with Obesity top bottom

The Book

OVERWEIGHT: What Kids Say explores the obesity problem from the often-overlooked perspective of children struggling with being overweight.

About Dr. Robert A. Pretlow

Dr. Robert A. Pretlow is a pediatrician and childhood obesity specialist. He has been researching and spreading awareness on the childhood obesity epidemic in the US for more than a decade.
You can contact Dr. Pretlow at:

Presentations

Dr. Pretlow’s invited presentation at the American Society of Animal Science 2020 Conference
What’s Causing Obesity in Companion Animals and What Can We Do About It

Dr. Pretlow’s invited presentation at the World Obesity Federation 2019 Conference:
Food/Eating Addiction and the Displacement Mechanism

Dr. Pretlow’s Multi-Center Clinical Trial Kick-off Speech 2018:
Obesity: Tackling the Root Cause

Dr. Pretlow’s 2017 Workshop on
Treatment of Obesity Using the Addiction Model

Dr. Pretlow’s invited presentation for
TEC and UNC 2016

Dr. Pretlow’s invited presentation at the 2015 Obesity Summit in London, UK.

Dr. Pretlow’s invited keynote at the 2014 European Childhood Obesity Group Congress in Salzburg, Austria.

Dr. Pretlow’s presentation at the 2013 European Congress on Obesity in Liverpool, UK.

Dr. Pretlow’s presentation at the 2011 International Conference on Childhood Obesity in Lisbon, Portugal.

Dr. Pretlow’s presentation at the 2010 Uniting Against Childhood Obesity Conference in Houston, TX.

Food & Health Resources